Tests a drug added to brain stimulation for depression
Tests D-cycloserine added to magnetic brain stimulation in adults with depression.
Key facts
- Who runs it
- Universiteit Maastricht
- Where
- Maastricht, NetherlandsSee the 2 sites
- Trial code
- Registry title
- TMSxDCS: Medicinal improvement of brain stimulation for depression.
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 48 people, planned
- Started
- 17 Aug 2026
- Expected to end
- 12 Dec 2027
- Type of study
- Interventional
- Record updated
- 21 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with major depression that has not improved enough with at least 2 antidepressant medicines. It tests brain stimulation (TMS) together with the medicine D-cycloserine.
- Age
- 18 to 65 years (the record also lists a maximum age of 64 years)
- Sex
- All sexes can join.
- Disease stage
- Major depressive disorder, a current moderate to severe episode (MADRS score above 20), treatment resistant.
- Earlier treatment
- Has tried at least 2 types of antidepressant medicine without enough effect. No change in antidepressant treatment (medicine or psychotherapy) in the 4 weeks before joining.
Main reasons for not taking part
- Pregnancy at joining or during the study
- Metal implants or a cochlear implant near the head
- Bipolar disorder, psychosis or schizophrenia in the past, or another main psychiatric diagnosis
- Kidney insufficiency in the past or current substance abuse disorder
- Use of olanzapine, clozapine, ethionamide or isoniazid, or regular scheduled use of benzodiazepines
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- A primary diagnosis of MDD, with a current moderate to severe depressive episode (score of >20 on the MADRS)
- Age between 18-65 years old
- A diagnosis of moderate to severe measures of treatment resistant depression (TRD) and have tried at least 2 types of antidepressant medication without sufficient result
Who cannot take part
- Any change in antidepressant treatment (medication, psychotherapy) 4 weeks prior to enrollment
- Has a cochlear implant
- Metal implants near (<10 cm away from coil) the head including: - Aneurysm clips / coils - Any medical implant containing metal near the head - Metal stents in the brain - Shrapnel or bullet fragments - Implanted vagus nerve or deep brain stimulators, Electrodes for monitoring brain activity
- Current scheduled use of benzodiazepines (as needed use is permitted, except for the day prior to treatment)
- Current use of any of the following medications: Olanzapine, clozapine, ethionamide, isoniazid
- Primary psychiatric diagnosis other than MDD
- A history of bipolar disorder
- A history of psychosis
- A history of schizophrenia
- A history of renal insufficiency
- Current substance abuse disorder
- Pregnancy upon inclusion or during the study period, though women with childbearing potential will be included into the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Netherlands
- Brain ModulationMaastricht, NetherlandsNot yet recruiting
- Universiteit MaastrichtMaastricht, NetherlandsNot yet recruiting
About the trial
What the trial wants to find out
The primary objective of this study is to investigate the antidepressive effect of augmenting a single day of accelerated transcranial magnetic stimulation (TMS) with D-cycloserine (DCS).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- TMSxDCS: Pharmacologically augmenting transcranial magnetic stimulation for depression
- Plain-language title
- Tests a drug added to brain stimulation for depressionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Fit questions
- Built from 2025-521166-95-00, who can take part
- Record updated
- 21 September 2026